当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件21130条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Valproate Semisodium
DRUG FOR FURTHER PROCESSING
0074-0805
AbbVie Inc.
20150722
DIVALPROEX SODIUM
EXPORT ONLY
125
0074-0805_2a24a1aa-b774-46ef-87f6-3b6b7902f4b3
RISANKIZUMAB
DRUG FOR FURTHER PROCESSING
0074-1058
AbbVie Inc.
20211026
RISANKIZUMAB
DRUG FOR FURTHER PROCESSING
150
0074-1058_2aef679d-a907-4451-ab4a-24b81bbb15c0
Risankizumab
BULK INGREDIENT
0074-1059
AbbVie Inc.
20240417
RISANKIZUMAB
BULK INGREDIENT
6396
0074-1059_78f8705e-e675-4f93-937e-8124aabde956
Risankizumab
BULK INGREDIENT
0074-1078
AbbVie Inc.
20241209
RISANKIZUMAB
BULK INGREDIENT
5600
0074-1078_ebbd63f4-e343-40f3-8283-efa91da3a92a
adalimumab
DRUG FOR FURTHER PROCESSING
0074-1115
AbbVie Inc.
20210923
ADALIMUMAB
DRUG FOR FURTHER PROCESSING
40
0074-1115_cdae7517-67ea-41c9-9230-75db518ce661
adalimumab
DRUG FOR FURTHER PROCESSING
0074-1117
AbbVie Inc.
20210927
ADALIMUMAB
DRUG FOR FURTHER PROCESSING
80
0074-1117_77fcbbc6-8b9a-4f8b-b998-098bd1d3e963
Adalimumab
BULK INGREDIENT
0074-1867
AbbVie Inc.
20230203
ADALIMUMAB
BULK INGREDIENT
1
0074-1867_e72a49fd-38c4-47c2-a07e-2e002fdf27d5
Upadacitinib
DRUG FOR FURTHER PROCESSING
0074-2241
AbbVie Inc.
20240614
UPADACITINIB
DRUG FOR FURTHER PROCESSING
45
0074-2241_1b44ab7a-8726-4595-8d8e-43de9ad677df
SOTATERCEPT
BULK INGREDIENT
0074-2242
AbbVie Inc.
20240617
SOTATERCEPT
BULK INGREDIENT
1
0074-2242_a4ce5c8c-bf2e-400d-bd20-3e922a4038b2
Upadacitinib
DRUG FOR FURTHER PROCESSING
0074-2250
AbbVie Inc.
20240628
UPADACITINIB
DRUG FOR FURTHER PROCESSING
30
0074-2250_9af0c50c-adb5-4811-a830-c7feef49e998
upadacitinib
DRUG FOR FURTHER PROCESSING
0074-2309
AbbVie Inc.
20240502
UPADACITINIB
DRUG FOR FURTHER PROCESSING
15
0074-2309_f789a545-3d28-4771-ba7a-fad1455b2aae
adalimumab
DRUG FOR FURTHER PROCESSING
0074-2330
AbbVie Inc.
20210927
ADALIMUMAB
DRUG FOR FURTHER PROCESSING
40
0074-2330_c2c4f850-070a-4fca-9e6a-51606995e5ac
Ibrutinib
DRUG FOR FURTHER PROCESSING
0074-2628
AbbVie Inc.
20231110
IBRUTINIB
DRUG FOR FURTHER PROCESSING
140
0074-2628_68d5b97b-8cae-4bb7-84df-9c089bd705e4
Risankizumab
DRUG FOR FURTHER PROCESSING
0074-5016
AbbVie Inc.
20240930
RISANKIZUMAB
DRUG FOR FURTHER PROCESSING
600
0074-5016_b69d15dc-1ce1-428d-b4f0-47a7e7e55cf8
Risankizumab
DRUG FOR FURTHER PROCESSING
0074-5025
AbbVie Inc.
20250404
RISANKIZUMAB
DRUG FOR FURTHER PROCESSING
600
0074-5025_af10e717-eef2-44ff-bfc6-d9ad773cd2bd
Cyclosporine
BULK INGREDIENT
0074-5503
AbbVie Inc.
20100524
CYCLOSPORINE
BULK INGREDIENT
1
0074-5503_9af962de-32dc-4f8b-ab89-f5d96f272270
atogepant
DRUG FOR FURTHER PROCESSING
0074-7091
AbbVie Inc.
20210915
ATOGEPANT
DRUG FOR FURTHER PROCESSING
10
0074-7091_2da718e4-a84f-47f1-a899-4721ca21fa84
atogepant
DRUG FOR FURTHER PROCESSING
0074-7092
AbbVie Inc.
20210915
ATOGEPANT
DRUG FOR FURTHER PROCESSING
30
0074-7092_2da718e4-a84f-47f1-a899-4721ca21fa84
atogepant
DRUG FOR FURTHER PROCESSING
0074-7093
AbbVie Inc.
20210915
ATOGEPANT
DRUG FOR FURTHER PROCESSING
60
0074-7093_2da718e4-a84f-47f1-a899-4721ca21fa84
Risankizumab
DRUG FOR FURTHER PROCESSING
0074-9000
AbbVie Inc.
20221117
RISANKIZUMAB
DRUG FOR FURTHER PROCESSING
180
0074-9000_928a30aa-9185-43e2-a4b3-877a8b5b2bd7
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3